82 filings
Page 4 of 5
8-K
3k8grc3k7gwvasj q0z
24 Nov 21
Kiromic Biopharma Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
4:22pm
8-K
5hzwojik4f6dpj
19 Nov 21
Other Events
9:45am
8-K
8arse 2tnuky4
29 Oct 21
Other Events
4:28pm
8-K
vfk7ynn e0eb9s
8 Oct 21
Regulation FD Disclosure
7:13am
8-K
vue2 adtv1
5 Oct 21
Departure of Directors or Certain Officers
4:47pm
8-K
s67wl77 6d3
13 Aug 21
Kiromic BioPharma Reports Second Quarter 2021 Financial Results and Operating Highlights
2:52pm
8-K
5hxyv704ye8 izjpr2tu
4 Aug 21
Other Events
12:38pm
8-K
ewm delc0lulu
28 Jul 21
Completion of Acquisition or Disposition of Assets
1:09pm
8-K
wfpzg97x0vsjfjgnbxpp
8 Jul 21
Entry into a Material Definitive Agreement
1:44pm
8-K
ssir0bilbvflg6f357il
30 Jun 21
Submission of Matters to a Vote of Security Holders
2:43pm
8-K
5wfu omirzj
17 Jun 21
Entry into a Material Definitive Agreement
1:38pm
8-K
x44br zqvzuo
7 Jun 21
Departure of Directors or Certain Officers
2:29pm
8-K
a05bx yatfvs87p8r0
14 May 21
Kiromic BioPharma Reports First Quarter 2021 Financial Results and Continued Corporate Progress
12:23pm
8-K
r4mt2ui731mi89q3bj
13 Apr 21
Entry into a Material Definitive Agreement
4:36pm
8-K
3gimlop
31 Mar 21
Kiromic BioPharma Reports Fiscal Year 2020 Financial Results and Continued Corporate Progress
11:14am
8-K
alsyu
12 Feb 21
Entry into a Material Definitive Agreement
4:30pm
8-K
mfdh41ik
29 Jan 21
Entry into a Material Definitive Agreement
4:30pm
8-K
oukx9pkea8k
17 Dec 20
Kiromic Announces Submission of Two IND Applications for PD1
11:22am
8-K
lzy4i 065yn9
30 Nov 20
Kiromic BioPharma Reports Third Quarter 2020 Financial Results and Continued Corporate Progress
4:31pm
8-K
vwpq79p4a1d5cvp 3bu
17 Nov 20
Other Events
5:03pm